Skip to content

Bio-Rad Laboratories, Inc. BIO.B Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Abbott logo
AbbottABT
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Revvity logo
RevvityRVTY
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Bio-Rad Laboratories, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets?
Bio-Rad Laboratories, Inc. (BIO.B) reported deferred tax assets and other non-current assets of $102.7M in Q4 2025.
How has Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets increased by 0.8% year-over-year, from $101.9M to $102.7M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s deferred tax assets and other non-current assets has grown at a 3.4% compound annual growth rate (CAGR), from $86.72M to $102.7M.